MOHAMMED ABDULFATAH (MD) – Rheumatology Physician, NPI 1285167023
Rheumatology Physician
Main info
Doctor Profile
Profile Insights
NPPES metrics only — not quality of care.
53 RHEUMATOLOGY in UT
Provider Addresses for MOHAMMED ABDULFATAH (MD)
30 N 1900 E RM 4C116
SALT LAKE CITY, UT 841320002
Phone: (801) 581-2121
Type: Mailing
8379 W SUNSET RD STE 210
LAS VEGAS, NV 891132243
Phone: (702) 968-2437
Type: Mailing
1768 VILLAGE PARK DR
ORANGEBURG, SC 291182457
Phone: (803) 359-2224
Fax: (803) 539-2234
Type: Location
NPPES updates history
No NPPES updates recorded for this provider.
Prescription Activity
Loading prescription activity...
Open Payments (CMS)
CMS reports 120 Open Payments records for all available years, with a total value of $2,470.
Total Amount is formed as General ($2,470) + Research ($0) + Ownership ($0) = $2,470.
Last reported payment date: 2024-12-18 • Largest payer in this snapshot: Amgen Inc. ($420).
Total Amount
$2,470
General + Research + Ownership
Payments
120
Total payment records
General Amount
$2,470
General payments
Research Amount
$0
Research funding
Ownership Amount
$0
Ownership interests
Ownership Count
0
Ownership records
Last Payment Date
2024-12-18
Latest reported date
Top Companies
Largest payers in this snapshot
| Company | Amount |
|---|---|
| Amgen Inc. | $420 |
| Novartis Pharmaceuticals Corporation | $373 |
| ABBVIE INC. | $277 |
| UCB, Inc. | $247 |
| Janssen Biotech, Inc. | $218 |
Medicare Enrollment & Revalidation
Source: CMS public data · Not endorsed by CMS ·
Educational use only—not medical, billing, or legal advice.
PECOS enrollment status
Participating (accepts Medicare assignment)
Enrollment effective: 2022-11-10
PECOS data refreshed: 2026-05-27
Medicare revalidation (CMS due date list)
Due date not assigned yet
CMS is tracking this Medicare enrollment for revalidation, but has not published a due date.
Enrollment records
1
Earliest due date
Not assigned (TBD)
CMS data updated
2026-06-01
Revalidation progress
- Medicare enrolled
- On CMS revalidation list
- Due date assigned
- Revalidate in PECOS
CMS enrollment records
| Enrollment ID | Type | Specialty | State | Due date |
|---|---|---|---|---|
| I20221110001526 | I | Rheumatology | SC | TBD |
What to do next
- No action required while the due date shows TBD.
- Check the CMS Revalidation Lookup Tool periodically — CMS updates the list about every 60 days.
- Do not submit a revalidation application in PECOS until CMS publishes a concrete due date.
Prepare CMS-855 application → · Look up this NPI in PECOS → · Verify on CMS PECOS
Medicare Utilization (FFS)
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·
Educational use only—not medical, billing, or legal advice.
Top Medicare procedures (2023) · refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Medicare allowed |
|---|---|---|---|---|
| J3262 | Injection, tocilizumab, 1 mg | 50,228 | 20 | $0 |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 8,275 | 21 | $0 |
| J0897 | Injection, denosumab, 1 mg | 1,800 | 25 | $0 |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 549 | 213 | $0 |
| 80053 | Blood test, comprehensive group of blood chemicals | 355 | 161 | $0 |
Insurance plans in this area (ZIP 84132)
Loading plans...
Group practice members
| Name | Specialty | State |
|---|---|---|
| R H E U M A T O L O G Y | CA | |
| R H E U M A T O L O G Y | CT | |
| Nurse Practitioner | NV | |
| Internal Medicine | NJ | |
| Physical Medicine And Rehabilitation | CA | |
| Infectious Disease | OH | |
| Nurse Practitioner | NV | |
| R H E U M A T O L O G Y | NV | |
| Nurse Practitioner | FL | |
| R H E U M A T O L O G Y | CA |
Reviews
All reviews are moderated before publication. Reviews reflect users' opinions; we do not verify the accuracy of individual reviews.
No reviews yet. Be the first to share your experience — your opinion helps families compare providers.